In research, our staff works on topics that are directly aligned with the research priorities of the Otto Loewi Research Center. The research questions are addressed in close collaboration with clinical departments, focusing both on basic research and potential clinical applications. The primary focus is on the molecular and chemical foundations of physiological and pathological processes in humans, as well as on drug discovery and development.
Our team focuses on the molecular mechanisms of the regulated interaction of intrinsically unstructured proteins and drug development in inflammation, autoimmunity and cancer.
Vascular research: Our researchers are investigating the impact of various substances (anticoagulants, antioxidants, nutritional supplements) and circumstances (age, menstrual cycle, orthostasis) on blood coagulation as well as the impact of oxidized lipoproteins on the development of endothelial dysfunction and atherosclerosis.
Nanomaterials for Drug Delivery: Our researchers are focusing on the synthesis and characterization of innovative nanomaterials for drug delivery applications.
Design and synthesis of artificial proteins: Our researchers have established an exciting and innovative new field of research: computer-assisted prediction and experimental synthesis of new proteins with specific properties.
Albumin and its different redox states: Our researchers explore albumin as a redox marker/redox regulator and prognostic marker in liver diseases as well as the binding and transport properties of albumin.
